Wangensteen Kirk J, Kalliainen Loree K
Hand (N Y). 2010 Sep;5(3):273-7. doi: 10.1007/s11552-009-9245-0. Epub 2009 Nov 24.
A chart review was conducted of all patients receiving NeuraGen® conduits from 2002 to 2007 at Regions Hospital, a level I trauma center. Ninety-six patients underwent 126 repairs using NeuraGen® conduits, and 64 patients were seen in follow-up. Repairs were largely of upper extremity sensory nerves but six were repairs of nerves elsewhere in the body. There were no intra-operative complications, but there were two minor postoperative complications and one postoperative pulmonary embolus. Forty of 126 repairs were lost to follow-up. Twenty-six of 126 repairs had follow-up with quantitative testing of nerve recovery (2-point discrimination, Semmes-Weinstein, or EMG testing), with 35% reporting improvement and 31% going on to a revision operation. Sixty of 126 repairs had qualitative testing performed (subjective or objective reporting of sensation or motor function), with 45% reporting improvement and 5% going on to a revision operation. Patients who went on to revision surgery were more likely to have undergone quantitative evaluation of sensation. Overall, sensory recovery was in the 35-45% range in our experience. Our results indicate that NeuraGen® collagen conduits can be used safely throughout the body.
对2002年至2007年期间在一级创伤中心地区医院接受NeuraGen®导管治疗的所有患者进行了病历审查。96例患者使用NeuraGen®导管进行了126次修复手术,其中64例患者接受了随访。修复手术主要针对上肢感觉神经,但有6例是对身体其他部位神经的修复。术中无并发症,但有2例轻微术后并发症和1例术后肺栓塞。126次修复手术中有40例失访。126次修复手术中有26例进行了神经恢复定量测试(两点辨别觉、Semmes-Weinstein或肌电图测试),35%的患者报告有改善,31%的患者进行了翻修手术。126次修复手术中有60例进行了定性测试(主观或客观报告感觉或运动功能),45%的患者报告有改善,5%的患者进行了翻修手术。接受翻修手术的患者更有可能接受过感觉定量评估。总体而言,根据我们的经验,感觉恢复率在35%-45%之间。我们的结果表明,NeuraGen®胶原蛋白导管可在全身安全使用。